A comprehensive view of Blood Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US to buy Amgen’s Nplate romiplostim injectable to treat acute radiation sickness in US$290.0M deal; drug treats blood cell injuries due to radiation and can be used during radiological, nuclear emergencies

Pfizer completes US$5.4B acquisition of sickle cell disease treatment specialist Global Blood Therapeutics; deal gives Pfizer a leading sickle cell disease portfolio and pipeline to address critical needs in underserved patient community

Kite Pharma receives FDA approval to start commercial production at its 100,000 square-foot retroviral vector manufacturing facility in Oceanside, California; viral vectors are used to manufacture cell therapies to treat certain blood cancers

BioMarin Pharmaceutical resubmits application to FDA for approval of injectable gene therapy valoctocogene roxaparvovec to treat severe hemophilia; if approved, the drug would be first commercially-available gene therapy in US to treat the condition

Hemostatic medical device firm Cresilon partners with Walter Reed Army Institute of Research to develop technologies to treat traumatic brain injuries; Cresilon's proprietary hemostatic gel technology stops bleeding in seconds without manual pressure

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count